Roger Crystal
Director/Board Member at MIND MEDICINE (MINDMED) INC.
Net worth: 115 028 $ as of 30/03/2024
Profile
Roger Crystal is currently a Director at Biotechnology Innovation Organization and an Independent Director at Mind Medicine (MindMed), Inc. He is also a member of Santa Monica Bay Chapter and YPO Santa Monica Bay Chapter.
Previously, he served as the President, Chief Executive Officer & Director at Opiant Pharmaceuticals, Inc. from 2009 to 2023 and as the Chief Business Officer at ImaginAb, Inc. from 2014 to 2016.
Dr. Crystal holds an undergraduate and doctorate degree from the University of Birmingham and an MBA from London Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
24/03/2024 | 12,237 ( 0.02% ) | 115 028 $ | 30/03/2024 |
Roger Crystal active positions
Companies | Position | Start |
---|---|---|
MIND MEDICINE (MINDMED) INC. | Director/Board Member | 10/08/2022 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
YPO Santa Monica Bay Chapter | Corporate Officer/Principal | - |
Santa Monica Bay Chapter
Santa Monica Bay Chapter Miscellaneous Commercial ServicesCommercial Services Santa Monica Bay Chapter provides social services. The private company is based in Fresno, CA. | Corporate Officer/Principal | - |
Former positions of Roger Crystal
Companies | Position | End |
---|---|---|
OPIANT PHARMACEUTICALS, INC. | Chief Executive Officer | 01/03/2023 |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Corporate Officer/Principal | 31/01/2016 |
Training of Roger Crystal
University of Birmingham | Doctorate Degree |
London Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MIND MEDICINE (MINDMED) INC. | Health Technology |
Private companies | 5 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
Santa Monica Bay Chapter
Santa Monica Bay Chapter Miscellaneous Commercial ServicesCommercial Services Santa Monica Bay Chapter provides social services. The private company is based in Fresno, CA. | Commercial Services |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Health Technology |
YPO Santa Monica Bay Chapter |
- Stock Market
- Insiders
- Roger Crystal